Calcium-mediated mechanisms of cystic expansion

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 10, 2011, Pages 1281-1290

  Abdul Majeed, Shakila ^a   Nauli, Surya M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Mechanosensor; Primary cilia; Shear stress; Signaling

Indexed keywords

BETA CATENIN; CALCIUM CHANNEL; CALCIUM ION; CALMODULIN; CYCLIC AMP; DISHEVELLED PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EVEROLIMUS; FIBROCYSTIN; FRIZZLED PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HAMARTIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE I; POLYCYSTIN 1; POLYCYSTIN 2; PROTEIN KINASE B; RAF PROTEIN; RAPAMYCIN; RAS PROTEIN; TUBERIN; UVOMORULIN; WNT PROTEIN;

CALCIUM SIGNALING; CALCIUM TRANSPORT; CATION TRANSPORT; CELL ADHESION; CELL CYCLE; CELL DIVISION; CELL GROWTH; CELL JUNCTION; CELL MATURATION; CELL MEMBRANE DEPOLARIZATION; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; DISEASE COURSE; DISEASE SEVERITY; DROSOPHILA; GENE EXPRESSION; GENE INDUCTION; GLOMERULUS FILTRATION RATE; HUMAN; IN VITRO STUDY; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MEMBRANE POTENTIAL; MITOSIS SPINDLE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SEQUENCE ANALYSIS; SHEAR STRESS; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM SIGNALING; CILIA; CYCLIC AMP; HUMANS; KIDNEY; MAP KINASE SIGNALING SYSTEM; MECHANOTRANSDUCTION, CELLULAR; MICE; MODELS, BIOLOGICAL; POLYCYSTIC KIDNEY DISEASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRPP CATION CHANNELS; WNT PROTEINS;

EID: 80052261599     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.09.016     Document Type: Review

References (107)

1. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995, 81:289-298.
2. Mochizuki T., Wu G., Hayashi T., Xenophontos S.L., Veldhuisen B., Saris J.J., Reynolds D.M., Cai Y., Gabow P.A., Pierides A., Kimberling W.J., Breuning M.H., Deltas C.C., Peters D.J., Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (New York, N.Y.) 1996, 272:1339-1342.
3. Ward C.J., Hogan M.C., Rossetti S., Walker D., Sneddon T., Wang X., Kubly V., Cunningham J.M., Bacallao R., Ishibashi M., Milliner D.S., Torres V.E., Harris P.C. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 2002, 30:259-269.
4. Cai Y., Maeda Y., Cedzich A., Torres V.E., Wu G., Hayashi T., Mochizuki T., Park J.H., Witzgall R., Somlo S. Identification and characterization of polycystin-2, the PKD2 gene product. J. Biol. Chem. 1999, 274:28557-28565.
5. Delmas P., Nomura H., Li X., Lakkis M., Luo Y., Segal Y., Fernandez-Fernandez J.M., Harris P., Frischauf A.M., Brown D.A., Zhou J. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J. Biol. Chem. 2002, 277:11276-11283.
6. Li Y., Santoso N.G., Yu S., Woodward O.M., Qian F., Guggino W.B. Polycystin-1 interacts with inositol 1, 4, 5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease. J. Biol. Chem. 2009, 284:36431-36441.
7. Parnell S.C., Magenheimer B.S., Maser R.L., Rankin C.A., Smine A., Okamoto T., Calvet J.P. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem. Biophys. Res. Commun. 1998, 251:625-631.
8. Bai C.X., Giamarchi A., Rodat-Despoix L., Padilla F., Downs T., Tsiokas L., Delmas P. Formation of a new receptor-operated channel by heteromeric assembly of TRPP2 and TRPC1 subunits. EMBO Rep. 2008, 9:472-479.
9. Kottgen M., Buchholz B., Garcia-Gonzalez M.A., Kotsis F., Fu X., Doerken M., Boehlke C., Steffl D., Tauber R., Wegierski T., Nitschke R., Suzuki M., Kramer-Zucker A., Germino G.G., Watnick T., Prenen J., Nilius B., Kuehn E.W., Walz G. TRPP2 and TRPV4 form a polymodal sensory channel complex. J. Cell Biol. 2008, 182:437-447.
10. Li Y., Wright J.M., Qian F., Germino G.G., Guggino W.B. Polycystin 2 interacts with type I inositol 1, 4, 5-trisphosphate receptor to modulate intracellular Ca2+ signaling. J. Biol. Chem. 2005, 280:41298-41306.
11. Ma R., Li W.P., Rundle D., Kong J., Akbarali H.I., Tsiokas L. PKD2 functions as an epidermal growth factor-activated plasma membrane channel. Mol. Cell. Biol. 2005, 25:8285-8298.
12. Tsiokas L., Arnould T., Zhu C., Kim E., Walz G., Sukhatme V.P. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc. Natl Acad. Sci. USA 1999, 96:3934-3939.
13. Gonzalez-Perrett S., Kim K., Ibarra C., Damiano A.E., Zotta E., Batelli M., Harris P.C., Reisin I.L., Arnaout M.A., Cantiello H.F. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc. Natl Acad. Sci. USA 2001, 98:1182-1187.
14. Vassilev P.M., Guo L., Chen X.Z., Segal Y., Peng J.B., Basora N., Babakhanlou H., Cruger G., Kanazirska M., Ye C., Brown E.M., Hediger M.A., Zhou J. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem. Biophys. Res. Commun. 2001, 282:341-350.
15. Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R., Ehrlich B.E., Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 2002, 4:191-197.
16. Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., Tsiokas L., Sukhatme V.P., Guggino W.B., Germino G.G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000, 408:990-994.
17. Tsiokas L., Kim E., Arnould T., Sukhatme V.P., Walz G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl Acad. Sci. USA 1997, 94:6965-6970.
18. Kim I., Fu Y., Hui K., Moeckel G., Mai W., Li C., Liang D., Zhao P., Ma J., Chen X.Z., George A.L., Coffey R.J., Feng Z.P., Wu G. Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J. Am. Soc. Nephrol. 2008, 19:455-468.
19. Kim I., Li C., Liang D., Chen X.Z., Coffy R.J., Ma J., Zhao P., Wu G. Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin. J. Biol. Chem. 2008, 283:31559-31566.
20. Wang S., Zhang J., Nauli S.M., Li X., Starremans P.G., Luo Y., Roberts K.A., Zhou J. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol. Cell. Biol. 2007, 27:3241-3252.
21. Bai C.X., Kim S., Li W.P., Streets A.J., Ong A.C., Tsiokas L. Activation of TRPP2 through mDia1-dependent voltage gating. EMBO J. 2008, 27:1345-1356.
22. Chauvet V., Tian X., Husson H., Grimm D.H., Wang T., Hiesberger T., Igarashi P., Bennett A.M., Ibraghimov-Beskrovnaya O., Somlo S., Caplan M.J. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J. Clin. Investig. 2004, 114:1433-1443.
23. Low S.H., Vasanth S., Larson C.H., Mukherjee S., Sharma N., Kinter M.T., Kane M.E., Obara T., Weimbs T. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev. Cell 2006, 10:57-69.
24. Nauli S.M., Alenghat F.J., Luo Y., Williams E., Vassilev P., Li X., Elia A.E., Lu W., Brown E.M., Quinn S.J., Ingber D.E., Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 2003, 33:129-137.
25. Nauli S.M., Rossetti S., Kolb R.J., Alenghat F.J., Consugar M.B., Harris P.C., Ingber D.E., Loghman-Adham M., Zhou J. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J. Am. Soc. Nephrol. 2006, 17:1015-1025.
26. Xu C., Rossetti S., Jiang L., Harris P.C., Brown-Glaberman U., Wandinger-Ness A., Bacallao R., Alper S.L. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am. J. Physiol. 2007, 292:F930-F945.
27. Xu C., Shmukler B.E., Nishimura K., Kaczmarek E., Rossetti S., Harris P.C., Wandinger-Ness A., Bacallao R.L., Alper S.L. Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells. Am. J. Physiol. 2009, 296:F1464-F1476.
28. AbouAlaiwi W.A., Takahashi M., Mell B.R., Jones T.J., Ratnam S., Kolb R.J., Nauli S.M. Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades. Circ. Res. 2009, 104:860-869.
29. Nauli S.M., Kawanabe Y., Kaminski J.J., Pearce W.J., Ingber D.E., Zhou J. Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 2008, 117:1161-1171.
30. Poelmann R.E., Van der Heiden K., Gittenberger-de Groot A., Hierck B.P. Deciphering the endothelial shear stress sensor. Circulation 2008, 117:1124-1126.
31. Hou B., Kolpakova-Hart E., Fukai N., Wu K., Olsen B.R. The polycystic kidney disease 1 (Pkd1) gene is required for the responses of osteochondroprogenitor cells to midpalatal suture expansion in mice. Bone 2009, 44:1121-1133.
32. Xiao Z., Zhang S., Mahlios J., Zhou G., Magenheimer B.S., Guo D., Dallas S.L., Maser R., Calvet J.P., Bonewald L., Quarles L.D. Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression. J. Biol. Chem. 2006, 281:30884-30895.
33. Masyuk A.I., Masyuk T.V., Splinter P.L., Huang B.Q., Stroope A.J., LaRusso N.F. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology 2006, 131:911-920.
34. Masyuk T.V., Huang B.Q., Ward C.J., Masyuk A.I., Yuan D., Splinter P.L., Punyashthiti R., Ritman E.L., Torres V.E., Harris P.C., LaRusso N.F. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology 2003, 125:1303-1310.
35. Bisgrove B.W., Snarr B.S., Emrazian A., Yost H.J. Polaris and Polycystin-2 in dorsal forerunner cells and Kupffer's vesicle are required for specification of the zebrafish left-right axis. Dev. Biol. 2005, 287:274-288.
36. McGrath J., Somlo S., Makova S., Tian X., Brueckner M. Two populations of node monocilia initiate left-right asymmetry in the mouse. Cell 2003, 114:61-73.
37. Vogel P., Read R., Hansen G.M., Freay L.C., Zambrowicz B.P., Sands A.T. Situs inversus in Dpcd/Poll-/-, Nme7-/-, and Pkd1l1-/- mice. Vet. Pathol. 2010, 47:120-131.
38. AbouAlaiwi W.A., Lo S.T., Nauli S.M. Primary cilia: highly sophisticated biological sensors. Sensors 2009, 9:7003-7020.
39. Kolb R.J., Nauli S.M. Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential. Front. Biosci. 2008, 13:4451-4466.
40. Nauli S.M., Zhou J. Polycystins and mechanosensation in renal and nodal cilia. Bioessays 2004, 26:844-856.
41. Praetorius H.A., Spring K.R. Removal of the MDCK cell primary cilium abolishes flow sensing. J. Membr. Biol. 2003, 191:69-76.
42. Siroky B.J., Ferguson W.B., Fuson A.L., Xie Y., Fintha A., Komlosi P., Yoder B.K., Schwiebert E.M., Guay-Woodford L.M., Bell P.D. Loss of primary cilia results in deregulated and unabated apical calcium entry in ARPKD collecting duct cells. Am. J. Physiol. 2006, 290:F1320-F1328.
43. Liu W., Murcia N.S., Duan Y., Weinbaum S., Yoder B.K., Schwiebert E., Satlin L.M. Mechanoregulation of intracellular Ca2+ concentration is attenuated in collecting duct of monocilium-impaired orpk mice. Am. J. Physiol. 2005, 289:F978-F988.
44. Habas R., Dawid I.B. Dishevelled and Wnt signaling: is the nucleus the final frontier?. J. Biol. 2005, 4:2.
45. Simons M., Gloy J., Ganner A., Bullerkotte A., Bashkurov M., Kronig C., Schermer B., Benzing T., Cabello O.A., Jenny A., Mlodzik M., Polok B., Driever W., Obara T., Walz G. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 2005, 37:537-543.
46. Kishimoto N., Cao Y., Park A., Sun Z. Cystic kidney gene seahorse regulates cilia-mediated processes and Wnt pathways. Dev. Cell 2008, 14:954-961.
47. van Rooijen E., Giles R.H., Voest E.E., van Rooijen C., Schulte-Merker S., van Eeden F.J. LRRC50, a conserved ciliary protein implicated in polycystic kidney disease. J. Am. Soc. Nephrol. 2008, 19:1128-1138.
48. Singla V., Reiter J.F. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science (New York, N.Y.) 2006, 313:629-633.
49. Veland I.R., Awan A., Pedersen L.B., Yoder B.K., Christensen S.T. Primary cilia and signaling pathways in mammalian development, health and disease. Nephron 2009, 111:39-53.
50. Saadi-Kheddouci S., Berrebi D., Romagnolo B., Cluzeaud F., Peuchmaur M., Kahn A., Vandewalle A., Perret C. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 2001, 20:5972-5981.
51. Lal M., Song X., Pluznick J.L., Di Giovanni V., Merrick D.M., Rosenblum N.D., Chauvet V., Gottardi C.J., Pei Y., Caplan M.J. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum. Mol. Genet. 2008, 17:3105-3117.
52. Happe H., Leonhard W.N., van der Wal A., van de Water B., Lantinga-van Leeuwen I.S., Breuning M.H., de Heer E., Peters D.J. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum. Mol. Genet. 2009, 18:2532-2542.
53. Kim E., Arnould T., Sellin L.K., Benzing T., Fan M.J., Gruning W., Sokol S.Y., Drummond I., Walz G. The polycystic kidney disease 1 gene product modulates Wnt signaling. J. Biol. Chem. 1999, 274:4947-4953.
54. Kim I., Ding T., Fu Y., Li C., Cui L., Li A., Lian P., Liang D., Wang D.W., Guo C., Ma J., Zhao P., Coffey R.J., Zhan Q., Wu G. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin. J. Am. Soc. Nephrol. 2009, 20:2556-2569.
55. Romaker D., Puetz M., Teschner S., Donauer J., Geyer M., Gerke P., Rumberger B., Dworniczak B., Pennekamp P., Buchholz B., Neumann H.P., Kumar R., Gloy J., Eckardt K.U., Walz G. Increased expression of secreted frizzled-related protein 4 in polycystic kidneys. J. Am. Soc. Nephrol. 2009, 20:48-56.
56. Muto S., Aiba A., Saito Y., Nakao K., Nakamura K., Tomita K., Kitamura T., Kurabayashi M., Nagai R., Higashihara E., Harris P.C., Katsuki M., Horie S. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum. Mol. Genet. 2002, 11:1731-1742.
57. Roitbak T., Ward C.J., Harris P.C., Bacallao R., Ness S.A., Wandinger-Ness A. A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol. Biol. Cell 2004, 15:1334-1346.
58. Sorenson C.M. Nuclear localization of beta-catenin and loss of apical brush border actin in cystic tubules of bcl-2 -/- mice. Am. J. Physiol. 1999, 276:F210-F217.
59. Fischer E., Legue E., Doyen A., Nato F., Nicolas J.F., Torres V., Yaniv M., Pontoglio M. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 2006, 38:21-23.
60. Jonassen J.A., San Agustin J., Follit J.A., Pazour G.J. Deletion of IFT20 in the mouse kidney causes misorientation of the mitotic spindle and cystic kidney disease. J. Cell Biol. 2008, 183:377-384.
61. Karner C.M., Chirumamilla R., Aoki S., Igarashi P., Wallingford J.B., Carroll T.J. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat. Genet. 2009, 41:793-799.
62. Patel V., Li L., Cobo-Stark P., Shao X., Somlo S., Lin F., Igarashi P. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 2008, 17:1578-1590.
63. Saburi S., Hester I., Fischer E., Pontoglio M., Eremina V., Gessler M., Quaggin S.E., Harrison R., Mount R., McNeill H. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat. Genet. 2008, 40:1010-1015.
64. Nishio S., Tian X., Gallagher A.R., Yu Z., Patel V., Igarashi P., Somlo S. Loss of oriented cell division does not initiate cyst formation. J. Am. Soc. Nephrol. 2010, 21:295-302.
65. Cheng J., Turkel N., Hemati N., Fuller M.T., Hunt A.J., Yamashita Y.M. Centrosome misorientation reduces stem cell division during ageing. Nature 2008, 456:599-604.
66. Arnould T., Kim E., Tsiokas L., Jochimsen F., Gruning W., Chang J.D., Walz G. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J. Biol. Chem. 1998, 273:6013-6018.
67. Nishio S., Hatano M., Nagata M., Horie S., Koike T., Tokuhisa T., Mochizuki T. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J. Clin. Investig. 2005, 115:910-918.
68. Omori S., Hida M., Fujita H., Takahashi H., Tanimura S., Kohno M., Awazu M. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J. Am. Soc. Nephrol. 2006, 17:1604-1614.
69. Parnell S.C., Magenheimer B.S., Maser R.L., Zien C.A., Frischauf A.M., Calvet J.P. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J. Biol. Chem. 2002, 277:19566-19572.
70. Yu W., Kong T., Beaudry S., Tran M., Negoro H., Yanamadala V., Denker B.M. Polycystin-1 protein level determines activity of the G{alpha}12/JNK apoptosis pathway. J. Biol. Chem. 2010, 285:10243-10251.
71. Togawa A., Miyoshi J., Ishizaki H., Tanaka M., Takakura A., Nishioka H., Yoshida H., Doi T., Mizoguchi A., Matsuura N., Niho Y., Nishimune Y., Nishikawa S., Takai Y. Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene 1999, 18:5373-5380.
72. Belibi F.A., Reif G., Wallace D.P., Yamaguchi T., Olsen L., Li H., Helmkamp G.M., Grantham J.J. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004, 66:964-973.
73. Hanaoka K., Guggino W.B. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J. Am. Soc. Nephrol. 2000, 11:1179-1187.
74. Yamaguchi T., Nagao S., Kasahara M., Takahashi H., Grantham J.J. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am. J. Kidney Dis. 1997, 30:703-709.
75. Yamaguchi T., Pelling J.C., Ramaswamy N.T., Eppler J.W., Wallace D.P., Nagao S., Rome L.A., Sullivan L.P., Grantham J.J. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int. 2000, 57:1460-1471.
76. Banales J.M., Masyuk T.V., Gradilone S.A., Masyuk A.I., Medina J.F., LaRusso N.F. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Hepatology (Baltimore, Md) 2009, 49:160-174.
77. Kip S.N., Hunter L.W., Ren Q., Harris P.C., Somlo S., Torres V.E., Sieck G.C., Qian Q. [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circ. Res. 2005, 96:873-880.
78. Wang X., Ward C.J., Harris P.C., Torres V.E. Cyclic nucleotide signaling in polycystic kidney disease. Kidney Int. 2010, 77:129-140.
79. Tortora G., Ciardiello F., Pepe S., Tagliaferri P., Ruggiero A., Bianco C., Guarrasi R., Miki K., Bianco A.R. Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients. Clin. Cancer Res. 1995, 1:377-384.
80. Yu S.M., Cheng Z.J., Kuo S.C. Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat. Br. J. Pharmacol. 1995, 114:1227-1235.
81. Sutters M., Yamaguchi T., Maser R.L., Magenheimer B.S., St John P.L., Abrahamson D.R., Grantham J.J., Calvet J.P. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kidney Int. 2001, 60:484-494.
82. Yamaguchi T., Wallace D.P., Magenheimer B.S., Hempson S.J., Grantham J.J., Calvet J.P. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J. Biol. Chem. 2004, 279:40419-40430.
83. Yamaguchi T., Hempson S.J., Reif G.A., Hedge A.M., Wallace D.P. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J. Am. Soc. Nephrol. 2006, 17:178-187.
84. Wang X., Harris P.C., Somlo S., Batlle D., Torres V.E. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrol. Dial. Transplant. 2009, 24:526-534.
85. Cowley B.D. Calcium, cyclic AMP, and MAP kinases: dysregulation in polycystic kidney disease. Kidney Int. 2008, 73:251-253.
86. Yamaguchi T., Nagao S., Wallace D.P., Belibi F.A., Cowley B.D., Pelling J.C., Grantham J.J. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int. 2003, 63:1983-1994.
87. Boca M., D'Amato L., Distefano G., Polishchuk R.S., Germino G.G., Boletta A. Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell mechanical adhesion. Mol. Biol. Cell 2007, 18:4050-4061.
88. Park E.Y., Sung Y.H., Yang M.H., Noh J.Y., Park S.Y., Lee T.Y., Yook Y.J., Yoo K.H., Roh K.J., Kim I., Hwang Y.H., Oh G.T., Seong J.K., Ahn C., Lee H.W., Park J.H. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J. Biol. Chem. 2009, 284:7214-7222.
89. Boletta A. Emerging evidence of a link between the polycystins and the mTOR pathways. PathoGenetics 2009, 2:6.
90. Lieberthal W., Levine J.S. The role of the mammalian target of rapamycin (mTOR) in renal disease. J. Am. Soc. Nephrol. 2009, 20:2493-2502.
91. Weimbs T. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?. Cell cycle (Georgetown, Tex) 2006, 5:2425-2429.
92. Bonnet C.S., Aldred M., von Ruhland C., Harris R., Sandford R., Cheadle J.P. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis. Hum. Mol. Genet. 2009, 18:2166-2176.
93. Hartman T.R., Liu D., Zilfou J.T., Robb V., Morrison T., Watnick T., Henske E.P. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum. Mol. Genet. 2009, 18:151-163.
94. Shillingford J.M., Murcia N.S., Larson C.H., Low S.H., Hedgepeth R., Brown N., Flask C.A., Novick A.C., Goldfarb D.A., Kramer-Zucker A., Walz G., Piontek K.B., Germino G.G., Weimbs T. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 2006, 103:5466-5471.
95. Gattone V.H., Sinders R.M., Hornberger T.A., Robling A.G. Late progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis. Kidney Int. 2009, 76:178-182.
96. Shillingford J.M., Piontek K.B., Germino G.G., Weimbs T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J. Am. Soc. Nephrol. 2010, 21:489-497.
97. Tao Y., Kim J., Schrier R.W., Edelstein C.L. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J. Am. Soc. Nephrol. 2005, 16:46-51.
98. Wahl P.R., Serra A.L., Le Hir M., Molle K.D., Hall M.N., Wuthrich R.P. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol. Dial. Transplant. 2006, 21:598-604.
99. Wu M., Arcaro A., Varga Z., Vogetseder A., Le Hir M., Wuthrich R.P., Serra A.L. Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease. Am. J. Physiol. 2009, 297:F1597-F1605.
100. Zafar I., Belibi F.A., He Z., Edelstein C.L. Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD). Nephrol. Dial. Transplant. 2009, 24:2349-2353.
101. Dere R., Wilson P.D., Sandford R.N., Walker C.L. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS ONE 2010, 5:e9239.
102. Kleymenova E., Ibraghimov-Beskrovnaya O., Kugoh H., Everitt J., Xu H., Kiguchi K., Landes G., Harris P., Walker C. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol. Cell 2001, 7:823-832.
103. Distefano G., Boca M., Rowe I., Wodarczyk C., Ma L., Piontek K.B., Germino G.G., Pandolfi P.P., Boletta A. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol. Cell. Biol. 2009, 29:2359-2371.
104. Fischer D.C., Jacoby U., Pape L., Ward C.J., Kuwertz-Broeking E., Renken C., Nizze H., Querfeld U., Rudolph B., Mueller-Wiefel D.E., Bergmann C., Haffner D. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol. Dial. Transplant. 2009, 24:1819-1827.
105. Serra A.L., Poster D., Kistler A.D., Krauer F., Raina S., Young J., Rentsch K.M., Spanaus K.S., Senn O., Kristanto P., Scheffel H., Weishaupt D., Wuthrich R.P. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J. Med. 2010, 363:820-829.
106. Walz G., Budde K., Mannaa M., Nurnberger J., Wanner C., Sommerer C., Kunzendorf U., Banas B., Horl W.H., Obermuller N., Arns W., Pavenstadt H., Gaedeke J., Buchert M., May C., Gschaidmeier H., Kramer S., Eckardt K.U. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J. Med. 2010, 363:830-840.
107. Watnick T., Germino G.G. mTOR inhibitors in polycystic kidney disease. N Engl J. Med. 2010, 363:879-881.